Skip to Content

Tag: twiist


twiist AID

Also Noted

Sequel Med Tech’s twiist now available nationwide

March 10, 2026HME News Staff

MANCHESTER, N.H. – Sequel Med Tech has announced broad national availability of its twist Automated Insulin Delivery (AID) System powered by Tidepool, following clearance by the U.S. Food and Drug Administration in 2024 and a subsequent controlled launch. “With twiist now accessible to more people than ever before, we’ve reached a meaningful milestone for Sequel and for people living with type 1 diabetes,” said Sequel CEO and Co-Founder Alan Lotvin, MD. “twiist was built...

automated insulin delivery, Diabetes, Sequel Med Tech, Tidepool, twiist


Read Full Articlered right arrow icon

Also Noted

Senseonics announces first patients using integrated twiist AID system, Eversense 365 CGM 

January 13, 2026HME News Staff

GERMANTOWN, Md. - Senseonics and Sequel MedTech have launched the integration of their products with the first patients receiving a Sequel twiist automated insulin delivery (AID) system paired with the implantable Eversense 365 continuous glucose monitor (CGM). The companies say pairing twiist with Eversense 365 is the first time the world’s only one year CGM system has been integrated with an...

Eversense CGM, Senseonics, twiist


Read Full Articlered right arrow icon

Also Noted

Sequel Med Tech collaborates with Abbott 

March 19, 2025HME News Staff

MANCHESTER, N.H. – Sequel Med Tech has announced that Abbott’s FreeStyle Libre 3 Plus sensor will be the first continuous glucose monitoring device to work with its twiist Automated Insulin Delivery (AID) System powered by Tidepool. The sensor will be compatible with twiist when the system is expected to launch in the second quarter of 2025. “We are thrilled to announce our collaboration with Abbott, integrating its world-leading FreeStyle Libre technology as our first CGM partner,...

Abbott, Continuous Glucose Monitor (CGM), Diabetes, FreeStyle Libre 3, Sequel Med Tech, twiist


Read Full Articlered right arrow icon